Abstract
Mast cell-derived chymase is implicated in myocardial fibrosis (MF), but the underlying mechanism of intracellular signaling remains unclear. Transforming growth factor-β1 (TGF-β1) is identified as the most important profibrotic cytokine, and Smad proteins are essential, but not exclusive downstream components of TGF-β1 signaling. Moreover, novel evidence indicates that there is a cross talk between Smad and mitogen-activated protein kinase (MAPK) signaling cascade. We investigated whether chymase activated TGF-β1/Smad pathway and its potential role in MF by evaluating cardiac fibroblasts (CFs) proliferation and collagen synthesis in neonatal rats. MTT assay and 3H-Proline incorporation revealed that chymase induced CFs proliferation and collagen synthesis in a dose-dependent manner. RT-PCR and Western blot assay demonstrated that chymase not only increased TGF-β1 expression but also upregulated phosphorylated-Smad2/3 protein. Furthermore, pretreatment with TGF-β1 neutralizing antibody suppressed chymase-induced cell growth, collagen production, and Smad activation. In contrast, the blockade of angiotensin II receptor had no effects on chymase-induced production of TGF-β1 and profibrotic action. Additionally, the inhibition of MAPK signaling had no effect on Smad activation elicited by chymase. These results suggest that chymase can promote CFs proliferation and collagen synthesis via TGF-β1/Smad pathway rather than angiotensin II, which is implicated in the process of MF.
Similar content being viewed by others
References
Brilla CG, Funck RC, Rupp H (2000) Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease. Circulation 102:1388–1393
Okada H, Takemura G, Kosai K et al (2005) Postinfarction gene therapy against transforming growth factor-beta signal modulates infarct tissue dynamics and attenuates left ventricular remodeling and heart failure. Circulation 111:2430–2437
Khan R, Sheppard R (2006) Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia. Immunology 118:10–24
Samuel CS, Unemori EN, Mookerjee I et al (2004) Relaxin modulates cardiac fibroblast proliferation, differentiation, and collagen production and reverses cardiac fibrosis in vivo. Endocrinology 145:4125–4133
Lijnen PJ, Petrov VV, Fagard RH (2000) Induction of cardiac fibrosis by transforming growth factor-beta(1). Mol Genet Metab 71:418–435
Hein S, Arnon E, Kostin S et al (2003) Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation 107:984–991
Holweg CT, Baan CC, Niesters HG et al (2001) TGF-beta1 gene polymorphisms in patients with end-stage heart failure. J Heart Lung Transplant 20:979–984
Urata H, Kinoshita A, Misono KS et al (1990) Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J Biol Chem 265:22348–22357
Urata H, Healy B, Stewart RW et al (1990) Angiotensin II-forming pathways in normal and failing heart. Circ Res 66:883–887
Li P, Chen PM, Wang SW et al (2002) Time-dependent expression of chymase and angiotensin converting enzyme in the hamster heart under pressure overload. Hypertens Res 25:757–762
Balcells E, Meng QC, Johnson WHJ et al (1997) Angiotensin II formation from ACE and chymase in human and animal hearts: methods and species considerations. Am J Physiol 273:H1769–H1774
Lindstedt KA, Wang Y, Shiota N et al (2001) Activation of paracrine TGF-beta1 signaling upon stimulation and degranulation of rat serosal mast cells: a novel function for chymase. FASEB J 15:1377–1388
Guo C, Ju H, Leung D et al (2001) A novel vascular smooth muscle chymase is upregulated in hypertensive rats. J Clin Invest 107:703–715
Shiota N, Jin D, Takai S et al (1997) Chymase is activated in the hamster heart following ventricular fibrosis during the chronic stage of hypertension. FEBS Lett 406:301–304
Wang Y, Shiota N, Leskinen MJ et al (2001) Mast cell chymase inhibits smooth muscle cell growth and collagen expression in vitro: transforming growth factor-beta1-dependent and -independent effects. Arterioscler Thromb Vasc Biol 21:1928–1933
Blobe GC, Schiemann WP, Lodish HF (2000) Role of transforming growth factor beta in human disease. N Engl J Med 342:1350–1358
Li G, Li RK, Mickle DA et al (1998) Elevated insulin-like growth factor-І and transforming growth factor-beta1 and their receptors in patients with idiopathic hypertrophic obstructive cardiomyopathy: a possible mechanism. Circulation 98:144–149
Rosenkranz S (2004) TGF-beta1 and angiotensin networking in cardiac remodeling. Cardiovasc Res 63:423–432
Akiyama-Uchida Y, Ashizawa N, Ohtsuru A et al (2002) Norepinephrine enhances fibrosis mediated by TGF-β in cardiac fibroblasts. Hypertension 40:148–154
Braun MU, Mochly-Rosen D (2003) Opposing effects of delta- and zeta-protein kinase C isozymes on cardiac fibroblast proliferation: use of isozyme-selective inhibitors. J Mol Cell Cardiol 35:895–903
Li PF, Dietz R, Harsdorf R et al (1999) Superoxide induces apoptosis in cardiomyocytes, but proliferation and expression of transforming growth factor-β1 in cardiac fibroblasts. FEBS Lett 448:206–210
Kapoun AM, Liang F, O’Young G et al (2004) B-Type natriuretic peptide exerts broad functional opposition to transforming growth factor-β in primary human cardiac fibroblasts-fibrosis, myofibroblast conversion, proliferation, and inflammation. Circ Res 94:453–461
Petrov VV, Fagard RH, Lijnen PJ (2002) Stimulation of collagen production by transforming growth factor-beta1 during differentiation of cardiac fibroblasts to myofibroblasts. Hypertension 39:258–263
Attisano L, Wrana JL (2002) Signal transduction by the TGF-beta superfamily. Science 296:1646–1647
Euler-Taimor G, Heger J (2006) The complex pattern of SMAD signaling in the cardiovascular system. Cardiovasc Res 69:15–25
Derynck R, Zhang YE (2003) Smad-dependent and Smad-independent pathways in TGF-beta family signaling. Nature 425:577–584
Schorb W, Booz GW, Dostal DE et al (1993) Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts. Circ Res 72:1245–1254
Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159
Lindstedt KA (1993) Inhibition of macrophage-mediated low density lipoprotein oxidation by stimulated rat serosal mast cells. J Biol Chem 268:7741–7746
Lindstedt L, Lee M, Castro GR et al (1996) Chymase in exocytosed rat mast cell granules effectively proteolyzes apolipoprotein A І-containing lipoproteins, so reducing the cholesterol efflux-inducing ability of serum and aortic intimal fluid. J Clin Invest 97:2174–2182
Rahimi RA, Leof EB (2007) TGF-β signaling: a tale of two responses. J Cell Biochem 102:593–608
Agocha A, Sigel AV, Eghbali-Webb M (1996) Characterization of adult human heart fibroblasts in culture: a comparative study of growth, proliferation and collagen production in human and rabbit cardiac fibroblasts and their response to transforming growth factor-beta1. Cell Tissue Res 288:87–93
Sigel AV, Centrella M, Eghbali-Webb M (1996) Autocrine and exogenous transforming growth factor-β regulate proliferative response of cardiac fibroblasts. J Mol Cell Cardiol 28:1921–1929
Derynck R, Akhurst RJ, Balmain A (2001) TGF-β signaling in tumor suppression and cancer progression. Nat Genet 29:117–129
Ghahary A, Tredget EE, Ghahary A et al (2002) Cell proliferating effect of latent transforming growth factor-beta1 is cell membrane dependent. Wound Repair Regen 10:328–335
Mori Y, Chen SJ, Varga J (2000) Modulation of endogenous Smad expression in normal skin fibroblasts by transforming growth factor-beta. Exp Cell Res 258:374–383
Rodriguez-Vita J, Sanchez-Lopez E, Esteban V et al (2005) Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-beta-independent mechanism. Circulation 111:2509–2517
Wang FM, Hu T, Tan H et al (2006) p38 Mitogen-activated protein kinase affects transforming growth factor-β/Smad signaling in human dental pulp cells. Mol Cell Biochem 291:49–54
Dziembowska M, Danilkiewicz M, Wesolowska A et al (2007) Cross-talk between Smad and p38 MAPK signaling in transforming growth factor beta signal transduction in human glioblastoma cells. Biochem Biophys Res Commun 354:1101–1106
Acknowledgments
We are grateful to Fa-Gen Lv, Hui Liu and Shao-Wei Liu for their kindly technical assistance and helpful suggestions. We also thank Li-Juan Li and Shu-Qing Ding for their careful proofreading on grammatical English of the manuscript. Especially, we are very indebted to Dr. Dhalla and reviewers for their comments on our article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhao, XY., Zhao, LY., Zheng, QS. et al. Chymase induces profibrotic response via transforming growth factor-β1/Smad activation in rat cardiac fibroblasts. Mol Cell Biochem 310, 159–166 (2008). https://doi.org/10.1007/s11010-007-9676-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-007-9676-2